{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:38Z","timestamp":1790803178623,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcf.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T20:07:06Z","timestamp":1509566826000},"page":"S62-S69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"S2","title":["Gallbladder and bile duct disease in Cystic Fibrosis"],"prefix":"10.1016","volume":"16","author":[{"given":"David N.","family":"Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Debray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells","volume":"105","author":"Cohn","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI116966","article-title":"Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization","volume":"93","author":"Strong","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOG.0b013e328352aab2","article-title":"The biliary HCO(3)(\u2212) umbrella: experimental evidence revisited","volume":"28","author":"Beuers","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-\u03baB-mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.28817","article-title":"The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity","volume":"64","author":"Fiorotto","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcf.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","article-title":"Induction of colitis in cftr\u2212\/\u2212 mice results in bile duct injury","volume":"287","author":"Blanco","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.28000","article-title":"Stimulation of nuclear receptor peroxisome proliferator-activated receptor-\u03b3 limits NF-\u03baB-dependent inflammation in mouse cystic fibrosis biliary epithelium","volume":"62","author":"Scirpo","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jcf.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/adc.50.10.769","article-title":"Aspects of bile acid metabolism in cystic fibrosis","volume":"50","author":"Goodchild","year":"1975","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0016-5085(19)31852-9","article-title":"Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement","volume":"73","author":"Watkins","year":"1997","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jcf.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gut.34.8.1137","article-title":"Intestinal bile acid malabsorption in cystic fibrosis","volume":"34","author":"O'Brien","year":"1993","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jcf.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1053\/j.gastro.2012.02.033","article-title":"Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis conductance regulator deficiencies","volume":"142","author":"Debray","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcomes","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jcf.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.006_bb0080","series-title":"Best practice guideline on liver disease in CF","year":"2017"},{"key":"10.1016\/j.jcf.2017.07.006_bb0085","series-title":"Disease of the liver and biliary system in children","author":"Kelly","year":"2008"},{"issue":"Suppl. 2","key":"10.1016\/j.jcf.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2017.07.006_bb0095","series-title":"Annual Data Report","author":"Cystic Fibrosis Foundation Patient Registry","year":"2014"},{"key":"10.1016\/j.jcf.2017.07.006_bb0100","first-page":"247","article-title":"Observations in cystic fibrosis of the pancreas. I. The gallbladder","volume":"110","author":"Esterly","year":"1962","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0105","first-page":"1","article-title":"Mucin histochemistry of human gallbladder: changes in adenocarcinoma, cystic fibrosis, and cholecystitis","volume":"40","author":"Esterly","year":"1968","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0110","first-page":"160","article-title":"Gallbladder anomalies and cystic fibrosis","volume":"62","author":"Isdale","year":"1982","journal-title":"S Afr Med J"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0115","first-page":"271","article-title":"\u201cMicro-gallbladder\u201d \u2013 a clue to cystic fibrosis","volume":"34","author":"Kramer","year":"1983","journal-title":"J Can Assoc Radiol"},{"issue":"710","key":"10.1016\/j.jcf.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1259\/0007-1285-60-710-137","article-title":"Ultrasound findings in children with cystic fibrosis","volume":"60","author":"McHugo","year":"1987","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000263744","article-title":"Prenatal diagnosis of cystic fibrosis: ultrasonography of the gallbladder at 17\u201319weeks of gestation","volume":"8","author":"Duchatel","year":"1993","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1016\/j.jcf.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.91.2.181","article-title":"Magnetic resonance imaging in young adults with cystic fibrosis","volume":"91","author":"Fiel","year":"1987","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00005176-199004000-00006","article-title":"Volume and emptying of the gallbladder in patients with cystic fibrosis","volume":"10","author":"Santamaria","year":"1990","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005176-198601000-00007","article-title":"Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis","volume":"5","author":"Stern","year":"1986","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/028418517301400512","article-title":"Micro-gallbladder and biliary calculi in mucoviscidosis","volume":"14","author":"Rovsing","year":"1973","journal-title":"Acta Radiol Diagn"},{"issue":"5","key":"10.1016\/j.jcf.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/hep.1840140505","article-title":"Gallstones in cystic fibrosis: a critical reappraisal","volume":"14","author":"Angelico","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.suc.2008.07.009","article-title":"Lithogenesis and bile metabolism","volume":"88","author":"Lambou-Gioanoukos","year":"2008","journal-title":"Surg Clin North Am"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/hep.510290634","article-title":"Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients","volume":"29","author":"Dray-Charier","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcf.2017.07.006_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11894-005-0053-6","article-title":"The gallbladder and biliary tract in cystic fibrosis","volume":"7","author":"Curry","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0170","first-page":"432","article-title":"Hepatobiliary scintigraphy in children with cystic fibrosis and liver disease","volume":"35","author":"Dogan","year":"1994","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9610(89)90698-3","article-title":"Operative therapy of gallbladder disease in patients with cystic fibrosis","volume":"157","author":"Synder","year":"1989","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2008-1066042","article-title":"Gallbladder disease in patients with cystic fibrosis","volume":"3","author":"Anagnostopoulos","year":"1993","journal-title":"Eur J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/SLE.0b013e318219a2b5","article-title":"Postoperative outcomes and quality of life in patients with cystic fibrosis undergoing laparoscopic cholecystectomy: a retrospective study","volume":"21","author":"Cogliandolo","year":"2011","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9610(06)80034-6","article-title":"Cholecystectomy as the treatment of choice in cystic fibrosis","volume":"160","author":"Bilton","year":"1990","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.jcf.2017.07.006_bb0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02944189","article-title":"Laparoscopic cholecystectomy in adult cystic fibrosis","volume":"166","author":"MGrath","year":"1997","journal-title":"Ir J Med Sci"},{"issue":"7","key":"10.1016\/j.jcf.2017.07.006_bb0200","first-page":"723","article-title":"Laparoscopic cholecystectomy under continuous epidural anesthesia in patients with cystic fibrosis","volume":"145","author":"Edelman","year":"1991","journal-title":"Am J Dis Child"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0205","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1213\/ANE.0b013e3181b845d0","article-title":"Perioperative management of the adult with cystic fibrosis","volume":"109","author":"Huffmyer","year":"2009","journal-title":"Anesth Analg"},{"issue":"6\u20137","key":"10.1016\/j.jcf.2017.07.006_bb0210","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1651-2227.1993.tb12754.x","article-title":"Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis","volume":"82","author":"Colombo","year":"1993","journal-title":"Acta Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2017.07.006_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcf.2017.07.006_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00365528809090231","article-title":"Sclerosing cholangitis in cystic fibrosis","volume":"143","author":"Standvik","year":"1988","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"8677","key":"10.1016\/j.jcf.2017.07.006_bb0225","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(89)92035-7","article-title":"Liver disease and bile duct abnormalities in adults with cystic fibrosis","volume":"2","author":"Nagel","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0230","first-page":"963","article-title":"Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency","volume":"21","author":"Waters","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0235","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0168-8278(99)80259-1","article-title":"Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study","volume":"30","author":"Durieu","year":"1999","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0240","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM198802113180602","article-title":"Liver disease and common-bile-duct stenosis in cystic fibrosis","volume":"318","author":"Gaskin","year":"1988","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.33.3.387","article-title":"Biliary complications of cystic fibrosis","volume":"33","author":"O'Brien","year":"1992","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jcf.2017.07.006_bb0250","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10620-015-3532-0","article-title":"Multidisciplinary treatment of cystic fibrosis-related recurrent pyogenic cholangitis (CF-RPC)","volume":"60","author":"Buxbaum","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0255","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0016-5085(82)90323-7","article-title":"Carcinoma of extrahepatic biliary system in an adult with cystic fibrosis","volume":"82","author":"Abdul-Karim","year":"1982","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jcf.2017.07.006_bb0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004836-199108000-00029","article-title":"Cholangiocarcinoma in an adult with cystic fibrosis","volume":"13","author":"Tesluk","year":"1991","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0265","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s10620-006-9259-1","article-title":"Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature","volume":"52","author":"Perdue","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.jcf.2017.07.006_bb0270","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/MEG.0b013e3282f4de7e","article-title":"Cholangiocarcinoma after lung transplant in a patient with cystic fibrosis","volume":"20","author":"Naderi","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2017.07.006_bb0275","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2017.07.006_bb0280","first-page":"CD000222","article-title":"Ursodeoxycholic acid for cystic fibrosis-related liver disease","volume":"12","author":"Cheng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.006_bb0290","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpeds.2016.05.008","article-title":"Long-term ursodeoxycholic acid therapy does not alter lithocholic acid levels in patients with cystic fibrosis with associated liver disease","volume":"177","author":"Colombo","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jcf.2017.07.006_bb0300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ciresp.2013.05.006","article-title":"Hepatolithiasis in cystic fibrosis: a special condition for surgical treatment","volume":"92","author":"Mon Mart\u00edn","year":"2014","journal-title":"Cir Esp"},{"issue":"1","key":"10.1016\/j.jcf.2017.07.006_bb0305","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.006_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13402","article-title":"Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study","author":"de Vries","year":"2017","journal-title":"Liver Int"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199317308214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199317308214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T11:38:10Z","timestamp":1572781090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199317308214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":62,"alternative-id":["S1569199317308214"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2017.07.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallbladder and bile duct disease in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}